Biological composition, efficacy and primary efficacy endpoint of SARS-CoV-2 vaccines: A special communication.

Severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, in late December 2019 and rapidly spread out globally, affecting 130 million individuals and starting a global pandemic. An efficacious vaccine is considered an essential tool to reduce mortality and morbidity rate related to the pandemic. Nine different vaccine candidates announced the efficacy results of their respective phase 3 trial testing up till January 2021.

Role of magnetic resonance cholangiopancreatography (MRCP) in learning anatomical variations in pancreatic duct.

Objective: To assess the frequency of anatomical variations of pancreatic duct through magnetic resonance cholangiography pancreatography. .

Methods: The cross-sectional prospective study was conducted from May 2011 to December 2012 at the Department of Anatomy, Institute of Basic Medical Sciences (IBMS), Dow University of Health Sciences, Karachi, in collaboration with the Department of Radiology, Aga Khan University Hospital, Karachi.